Kutse

WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ REGIONALBÜRO FÜR EUROPA ЗДРАВООХРАНЕНИЯ ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Regional meeting on the Implementation of the Tuberculosis (TB) Action Plan for the WHO European Region 2023–2030 for TB high-priority countries Venue: Renaissance Istanbul Polat Hotel, Istanbul, Türkiye 3 October 2022 Time: 21–24 November 2022 Original: English SCOPE AND PURPOSE BACKGROUND Tuberculosis (TB) and drug-resistant TB (DR-TB) continue to represent major public health threats in the WHO European Region. The European Region has achieved notable progress in reducing overall TB incidence and mortality. However, the Region is confronted with challenges in reducing the burden of DR-TB and addressing the issue of TB/HIV coinfection, both of which continue to cause premature mortality in the Region. Challenges such as the coronavirus disease (COVID-19) pandemic have severely affected the progress made in the Region towards reaching TB targets as, from 2020, pandemic responses have led to service disruptions and barriers in accessing care, resulting in substantial reductions in the numbers of both TB notifications and people being enrolled onto treatment, especially for multidrug-resistant TB (MDR-TB)/rifampicin-resistant TB (RR-TB). In addition, the war in Ukraine has triggered an escalating humanitarian crisis in Europe that may have a serious impact on progress towards meeting regional TB targets. While new options for TB prevention, diagnosis, treatment and service delivery provide opportunities to accelerate the TB response, the Region’s national health systems are still recovering from the setbacks caused by the COVID-19 pandemic, and more challenges are anticipated due to the humanitarian crisis in Europe. At the 72nd session of the WHO Regional Committee for Europe, Member States of the European Region endorsed the TB Action Plan for the WHO European Region 2023–2030. To reinforce Region-specific efforts to reduce TB incidence by 90% by 2030, the Action Plan defines the priorities for Member States in this new operating context and reflects the urgency to get back on track to meet WHO’s End TB Strategy targets. The Action Plan outlines the overall vision and strategic actions to end the TB burden in the WHO European Region by 2030, in line with End TB Strategy, and sets out the milestones and targets required to achieve this goal and the commitments made at the United Nations General Assembly High-level Meeting on the Fight Against Tuberculosis for 2018–2022. The Action Plan strategically combines the disease-specific approach with a health system approach and places people at the centre of the response, in line with the European Programme of Work, 2020–2025 – “United Action for Better Health in Europe”. In order to initiate the implementation of the Action Plan in Member States, and to align national responses to the targets and priority actions described in the Action Plan, the WHO Regional Office for Europe will conduct a regional meeting on the Implementation of the Tuberculosis Action Plan for the WHO European Region 2023–2030 for TB high-priority countries in Istanbul, Türkiye, on 21– 24 November 2022 for the 18 high-priority countries in the WHO European Region. The regional meeting will be conducted in close collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Stop TB Partnership and the United States Agency for International Development (USAID). This will be an in-person meeting with the possibility of joining remotely (hybrid mode).  Page 2 OBJECTIVES  To launch the implementation of the TB Action Plan for the WHO European Region 2023–2030.  To discuss strategic priorities and policy-level actions, and discuss next steps towards the United Nations General Assembly High-level Meeting in 2023.  To discuss and agree on priority actions against TB and DR-TB to be taken by countries, WHO, the Stop TB Partnership, the Global Fund, USAID and other partners for the first period of implementation of the Action Plan during 2023–2025.  To support alignment of the national strategic plans for TB with the TB Action Plan for the WHO European Region 2023–2030.  To equip countries with tools for preparing applications to the new cycle of funding allocation by the Global Fund for 2024–2026. WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 13 October 2022 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONAL OFFICE FOR EUROPE Mr Peep Peterson BUREAU RÉGIONAL DE L’EUROPE REGIONALBÜRO FÜR EUROPA Minister of Health and Labour ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Ministry of Social Affairs Suur-Ameerika 1 Head office: UN City, 51 Marmorvej, DK-2100 Copenhagen Ø, Tallinn 10129 Denmark Estonia Telephone: +45 45 33 70 00; Fax: +45 45 33 70 01; Email: [email protected] Website: http://www.euro.who.int Dear Sir, Regional meeting on the Implementation of the Tuberculosis (TB) Action Plan for the WHO European Region 2023–2030 for TB high-priority countries 21–24 November 2022, Istanbul, Türkiye I have the honour to inform you that the WHO Regional Office for Europe plans to hold a meeting dedicated to the implementation of the TB Action Plan for the WHO European Region 2023–2030, which was endorsed by the WHO Regional Committee for Europe at its 72nd session in September 2022. For 21-24 November 2022 (4 days), I have the pleasure of inviting you to nominate a maximum of two participants who are involved in the development of national strategic plan for TB and responsible for: • supervision and management of the national TB programme; and • clinical management of TB and multidrug-resistant TB; Additionally, I invite you to nominate a deputy minister of health who oversees the national TB response in your country to attend the meeting on 23–24 November (2 days). Travel for participants will be arranged and paid for by this office, and they will also receive a daily subsistence allowance for the duration of the meeting in accordance with our travel regulations. More information about this meeting is provided in the Scope and purpose document included with this letter. I look forward to receiving your nominations, including their names, functional titles and contact information, at your earliest convenience but no later than 31 October 2022. Please email them to [email protected] and copy Dr Askar Yedilbayev, Regional Adviser on TB and drug-resistant TB, [email protected]. Yours very truly, Dr Hans Henri P Kluge Regional Director UN City, 51 Marmorvej Telephone: +45 45 33 70 00 E-mail: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Web site: http://www.euro.who.int Denmark Encl.: Scope and purpose Copy for information: Ms Elen Ohov Adviser European Union Affairs and International Co-operation Department Ministry of Social Affairs Suur- Ameerika 1 Tallinn 10122 Estonia Ms Triin Uusberg Head European Union Affairs and International Co-operation Department Ministry of Social Affairs Suur- Ameerika 1 Tallinn 10129 Estonia H.E. Ms Katrin Saarsalu-Layachi Ambassador Extraordinary and Plenipotentiary, Permanent Representative Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva Chemin du Petit-Saconnex 28A Genève CH-1209 Switzerland H.E. Mr William Mart Laanemäe Ambassador Extraordinary and Plenipotentiary Embassy of the Republic of Estonia Frederiksgade 19, 4th floor Copenhagen K 1265 Denmark Ms Kristina Köhler Liaison Officer WHO Country Office, Estonia Paldiski Road 81 Tallinn 10617 Estonia –2– Saatja: EURO TB <[email protected]> Saadetud: 13.10.2022 12:29 Adressaat: Peep Peterson <[email protected]>; Triin Uusberg <[email protected]>; Elen Ohov <[email protected]> Koopia: Elen Ohov <[email protected]>; Triin Uusberg <[email protected]>; SM Info <[email protected]>; Ms K. Saarsalu-Layachi <[email protected]>; <[email protected]>; Kaisa.Mitt-Alvarez <[email protected]>; <[email protected]>; <[email protected]>; KÖHLER, Kristina <[email protected]>; YEDILBAYEV, Askar <[email protected]> Teema: Request for Nomination: Regional meeting on the Implementation of the Tuberculosis (TB) Action Plan for the WHO European Region 2023-2030 and back-to-back TAG-TB meeting, 21-25 November 2022, Istanbul, Turkiye Dear Madam/Sir, Please see the attached correspondence sent from the World Health Organization, Regional Office for Europe. One or more attachments may be included. Veuillez vous r¨¦f¨¦rer ¨¤ la correspondance ci-jointe du Bureau r¨¦gional de l'Europe de l'Organisation mondiale de la sant¨¦. Une ou plusieurs annexes peuvent ¨ºtre jointes. Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen), Weltgesundheitsorganisation, Regionalb¨¹ro f¨¹r Europa. §³§Þ. §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§Ö §á§Ú§ã§î§Þ§Ñ §à§ä §¦§Ó§â§à§á§Ö§Û§ã§Ü§à§Ô§à §â§Ö§Ô§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ò§ð§â§à §£§ã§Ö§Þ§Ú§â§ß§à§Û §à§â§Ô§Ñ§ß§Ú§Ù§Ñ§è§Ú§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ (§à§Õ§Ú§ß §Ú§Ý§Ú §ß§Ö§ã§Ü§à§Ý§î§Ü§à §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§ç §æ§Ñ§Û§Ý§à§Ó).